Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 2566 to 2580 of 9006 results

  1. Teplizumab for delaying the onset of stage 3 type 1 diabetes in people 8 years and over with stage 2 type 1 diabetes [ID6259]

    In development Reference number: GID-TA10981 Expected publication date: TBC

  2. Eplontersen for treating transthyretin-related amyloidosis cardiomyopathy [ID6759]

    Awaiting development Reference number: GID-TA11551 Expected publication date: TBC

  3. Imlunestrant for treating oestrogen receptor-positive HER2-negative advanced breast cancer after endocrine therapy [ID6373]

    In development Reference number: GID-TA11439 Expected publication date: TBC

  4. High Definition – transcranial Electrical Stimulation (HD-tES) for fibromyalgia

    Topic prioritisation

  5. Endoscopic ultrasound guided radiofrequency ablation (EUS-RFA) system for pancreatic cystic neoplasms and neuroendocrine tumours

    Topic prioritisation

  6. Helium plasma coagulation for treating Respiratory Papillomatosis

    Topic prioritisation

  7. Transnasal Panendoscopy

    Topic prioritisation

  8. Chemical Component Separation

    Topic prioritisation

  9. Intralesional cryotherapy for keloid scars

    Topic prioritisation

  10. Seminal Vesicle Lavage

    Topic prioritisation

  11. Transnasal endoscopy

    Topic prioritisation

  12. Vascular Robotics

    Topic prioritisation

  13. Transvenous embolisation of cranial Arteriovenous Malformation

    Topic prioritisation

  14. EUS guided portal pressure measurement

    Topic prioritisation

  15. Phalloplasty

    Topic prioritisation